This inventor holds 5 USPTO granted patents and 9 published patent applications. Top assignee: Nutcracker Therapeutics, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Ole Haabeth
Introduction
Ole Haabeth is a prominent inventor based in Emeryville, CA, known for his significant contributions to the field of mRNA technology. With a total of four patents to his name, he has been at the forefront of developing innovative treatments that harness the power of messenger RNA.
Latest Patents
Among his latest patents are groundbreaking advancements in mRNA treatment nanoparticles. These nanoparticles are designed to treat patients by encapsulating one or more mRNAs that encode tumor-specific antigens and immunomodulatory agents. Additionally, he has developed mRNA therapeutic compositions aimed at multimodal mRNA-based immunotherapies, which deliver both antigens and immunomodulators. These technologies represent a significant leap forward in the treatment of various diseases.
Career Highlights
Ole Haabeth is currently associated with Nutcracker Therapeutics, Inc., where he continues to push the boundaries of mRNA research. His work has garnered attention for its potential to revolutionize how immunotherapies are administered and developed.
Collaborations
He collaborates with notable colleagues such as Samuel Deutsch and Daniel Frimannsson, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Ole Haabeth's work in mRNA technology exemplifies the spirit of innovation in the medical field. His patents and ongoing research hold promise for future advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile